secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABEONA THERAPEUTICS INC. (ABEO)
CIK:        0000318306
Form:       8-K
Filed at:   2021-09-21T23:59:59+00:00
Accession:  0001493152-21-023269
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Abeona appoints new CEO, chairman; prepares for two BLA submissions
-------------------------------------------------------------------

- Michael Amoroso resigns as President/CEO effective Oct 14, 2021; appointed Chairman Oct 15.
- Steven Rouhandeh retires as Chairman and board member effective Oct 14, 2021.
- Vishwas Seshadri appointed President/CEO and director effective Oct 15; base salary $500K plus equity.
- Promotions: Brendan O'Malley to General Counsel, Brian Kevany to CTO; adds regulatory veterans Carl Denny and Kate Imhoff.
- Leadership changes aim to support two BLA submissions for EB-101 (RDEB) and ABO-102 (MPS IIIA).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/318306/000149315221023269/0001493152-21-023269-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/318306/000149315221023269/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-023269

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer